Albeit more detailed studies are needed, but the inhibition of PI3K/Akt pathway during ex vivo expansion seems to be a promising and encouraging strategy for producing T cells with a less differentiated state (TN/TCM phenotype) and improving their in vivo persistence and anti-tumor efficacy (Figure 4). This evidence concerns the gene PIK3CD and neoplasm.